Speaking

Talks about the story of rapamycin — and the science of staying curious.

I speak with health-conscious and curious groups — longevity practices, health retreats, clinical teams, and thoughtful communities — about the history of rapamycin told through a storyteller's lens. Together we follow the medicine from a remote Pacific island to the questions we still have, making room for wonder, humility, and the willingness to be wrong.

Talks on offer

45 MIN + Q&A

The remarkable story of rapamycin — and how I became part of it

KEYNOTE · HEALTH & WELLNESS · LONGEVITY · CURIOUS COMMUNITIES

A storyteller’s journey through one of the strangest stories in modern medicine — from a soil sample collected on a remote Pacific island, to Mikhail Blagosklonny’s provocative ideas about aging, to physician Alan Green’s willingness to explore them in practice, and finally to my own decision to become a patient. It’s a story about discovery, scientific courage, uncertainty, and what happens when curious people encounter a medicine before medicine has all the answers. The keynote ends with an invitation to stay curious — and, for those who want to go deeper, to continue the conversation in the Rapa-Curious workshop.

60 MIN · GREGG + PHYSICIAN

The proven, the promising, the hyped — and the still science fiction

LONGEVITY PRACTICES · HEALTH & WELLNESS · CURIOUS COMMUNITIES

Think less panel discussion. More jazz. Gregg joins a practicing physician for a lively, unscripted exploration of longevity medicine — what we know, what looks promising, what may be getting ahead of the evidence, and what still belongs to the future. From exercise and prevention to rapamycin, senolytics, biomarkers, and cellular reprogramming, patient experience meets clinical judgment — with room for agreement, disagreement, curiosity, and the willingness to say, “We don’t know yet.”

90–120 MIN · INTERACTIVE WORKSHOP

Rapa-Curious: Going deeper

KEYNOTE FOLLOW-UP · LONGEVITY PRACTICES · HEALTH & WELLNESS · CURIOUS COMMUNITIES

The keynote tells the story. The workshop opens the notebook. A smaller, participatory conversation for people who want to explore rapamycin more deeply — the evidence, the uncertainties, the animal and human research, dosing concepts, risks, and the questions worth asking before drawing conclusions. Gregg brings the patient perspective and years of lived curiosity. When appropriate, a prescribing physician joins the conversation to bring clinical experience and judgment. No prescriptions. No sales pitch. Better questions.

Booking

Invite me to speak.

Tell me a little about what you’re planning. I read every inquiry personally and will be in touch within a few days.